DMH4 – 25 mg

Brand:
Cayman
CAS:
515880-75-8
Storage:
-20
UN-No:
Non-Hazardous - /

DMH4 is an inhibitor of VEGF receptor 2 (VEGFR2; IC50 = 0.16 µM in a cell-free assay) and a derivative of dorsomorphin (Item No. 11967).{28912} It selectively inhibits VEGFR2 over activin receptor-like kinase 2 (ALK2), ALK5, and AMPK (IC50s = 3.5, >30, and 8 µM, respectively, in a cell-free assay). DMH4 inhibits growth of H460 and A549 human lung cancer cells (GI50s = 13.3 and 2.8 µM, respectively) and reduces VEGF-induced tubule formation in human umbilical vein endothelial cells (HUVECs; IC50 = 1 µM).{28912,53048}  

 

Available on backorder

SKU: 27653 - 25 mg Category:

Description

A VEGFR2 inhibitor (IC50 = 0.16 µM in a cell-free assay); selectively inhibits VEGFR2 over ALK2, ALK5, and AMPK (IC50s = 3.5, >30, and 8 µM, respectively, in a cell-free assay); inhibits growth of H460 and A549 cancer cells (GI50s = 13.3 and 2.8 µM, respectively) and reduces VEGF-induced tubule formation in HUVECs (IC50 = 1 µM)


Formal name: 6-[4-[2-(4-morpholinyl)ethoxy]phenyl]-3-phenyl-pyrazolo[1,5-a]pyrimidine

Synonyms: 

Molecular weight: 400.5

CAS: 515880-75-8

Purity: ≥98%

Formulation: A solid


Product Type|Biochemicals|Kinase Inhibitors|VEGFR Family||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Angiogenesis||Research Area|Cancer|Cell Signaling|Growth Factor Receptor Signaling